Table 3.
Items | Univariate logistic regression | Multivariate logistic regression | ||
---|---|---|---|---|
P value | OR (95%CI) | P value | OR (95%CI) | |
lnc‐ANRIL/miR‐125a axis (high vs low) | <0.001 | 5.812 (2.456‐13.754) | 0.002 | 8.946 (2.310‐34.654) |
Age (≥56 vs < 56 y) | 0.166 | 0.585 (0.274‐1.248) | 0.105 | 0.360 (0.104‐1.238) |
Gender (male vs female) | 0.888 | 0.945 (0.429‐2.079) | 0.087 | 0.321 (0.088‐1.179) |
BMI (≥22.5 vs < 22.5 kg/m2) | 0.903 | 0.955 (0.451‐2.021) | 0.755 | 1.227 (0.340‐4.435) |
Scr (≥1.7 vs < 1.7 mg/dL) | 0.016 | 2.623 (1.195‐5.762) | 0.010 | 9.328 (1.711‐50.839) |
Albumin (≥24.7 vs < 24.7 g/L) | 0.058 | 0.475 (0.220‐1.025) | 0.373 | 0.523 (0.126‐2.177) |
WBC (≥18.4 vs < 18.4 × 109/L) | 0.252 | 1.556 (0.730‐3.316) | 0.186 | 0.368 (0.083‐1.620) |
CRP (≥103.6 vs < 103.6 mg/L) | 0.128 | 1.808 (0.844‐3.872) | 0.397 | 0.487 (0.092‐2.574) |
PCT (≥14.2 vs < 14.2 ng/mL) | 0.023 | 2.459 (1.130‐5.351) | 0.041 | 2.475 (1.037‐5.907) |
APACHE II score (≥14 vs < 14) | 0.031 | 2.346 (1.079‐5.101) | 0.775 | 0.814 (0.197‐3.354) |
SOFA score (≥5 vs < 5) | <0.001 | 4.818 (2.086‐11.131) | 0.048 | 4.542 (1.014‐20.349) |
TNF‐α (≥195.0 vs < 195.0 pg/mL) | 0.252 | 1.556 (0.730‐3.316) | 0.702 | 1.175 (0.514‐2.683) |
IL‐6 (≥61.9 vs < 61.9 pg/mL) | 0.702 | 1.158 (0.546‐2.454) | 0.653 | 0.828 (0.364‐1.884) |
IL‐8 (≥54.6 vs < 54.6 pg/mL) | <0.001 | 7.097 (2.911‐17.300) | <0.001 | 73.388 (8.843‐609.048) |
IL‐17 (≥129.4 vs < 129.4 pg/mL) | 0.003 | 3.400 (1.525‐7.578) | 0.111 | 3.569 (0.748‐17.041) |
Continuous variables were divided by the median values. P value < 0.05 was considered significant.
Abbreviations: APACHE II, acute physiology and chronic health evaluation II; BMI, body mass index; CI, confidence interval; CRP, C‐reactive protein; IL, interleukin; OR, odds ratio; PCT, procalcitonin; Scr, serum creatinine; SOFA, sequential organ failure assessment; TNF‐α, tumor necrosis factor‐α; WBC, white blood cell.